Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial

F. Gueyffier; F. Subtil; T. Bejan-Angoulvant; Y. Zerbib; J. P. Baguet; J. M. Boivin; A. Mercier; G. Leftheriotis; J. P. Gagnol; J. P. Fauvel; C. Giraud; G. Bricca; Delphine Maucort-Boulch; S. Erpeldinger

Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial

F. Gueyffier F. Subtil T. Bejan-Angoulvant Y. Zerbib J. P. Baguet J. M. Boivin A. Mercier G. Leftheriotis J. P. Gagnol J. P. Fauvel C. Giraud G. Bricca Delphine Maucort-Boulch ¹ S. Erpeldinger

1 Biostatistiques santé

Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadatas

https://hal-univ-lyon1.archives-ouvertes.fr/hal-02044768
Contributor : Laure-Hélène Davoine <>
Submitted on : Thursday, February 21, 2019 - 4:18:40 PM
Last modification on : Monday, May 20, 2019 - 9:50:25 AM

Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial

Identifiers

Collections

Citation

Export

Metrics

9

Contact

Can we identify response markers to antihypertensive drugs? First results from the Ideal Trial

Identifiers

Collections

Citation

Export

Share

Metrics

9

Contact